HORIBA

HORIBA is a French company founded in 1945. It designs, develops and distributes in vitro diagnostic systems throughout the world, mainly intended for biological analysis in medical laboratories.
HORIBA Medical is a world leader in the hematology market. It is present in more than 110 countries on five continents, 3 production plants around the world ( Montpellier, Kyoto and São Paulo ).

HORIBA Medical segments in the IVD area

  • Hematology
  • Chemistry
  • Coagulation

Own Medical Quality Policy , in addition:

ISO9001-2008. Quality management standard

ISO14001-2004. Environmental Management Standard)

ISO13485-2012. Quality system standard designed specifically for medical device companies

OHSAS 18001-2007. Health and Safety Assessment Series Occupational

Specifications

yumizen G400

Compact 4-channel equipment dedicated to laboratories with low volume of samples to perform coagulation screening.

  • Analysis Efficiency
  • Analysis Efficiency
  • Increased efficiency
  • Easy drive

Analysis Efficiency

  • 4 independent measurement channels
  • 20 incubation positions
  • Easy to use, innovative user interface
  • Quality Control Management
  • Calibration master curve (no calibration required)

Security

  • Barcode reading (optional)
  • Data storage (USB)
  • Ready-to-use reagents user interface

Increased efficiency

  • 3 reference measurement methods: coagulative, turbidimetric and chromogenic
  • 20 incubation positions
  • Free of mantenimient

Easy drive

  • Internal storage capacity
  • integrated printer
  • Small dimensions (Width: 20 cm; Height: 8 cm; Depth: 32 cm; Weight: 2.55 kg)
  • Multiple connectivity:
    Laboratory information system
    Optional Yumizen G management software

Parameters

  • Coagulative tests (640 nm)
    Screening test (PT, APTT, Fibrinogen and TT)
    Factors (II, V, VII, X, VIII, IX, XI, XII)
  • Turbidimetric test (570 nm)
    D-Dimer*
  • Chromogenic test (405 nm)
    ATIII*

Specifications

yumizen G200

The most extensive dedicated test menu on the market offering the consolidation of routine and specialized tests in a single platform, which means further cost savings. These tests include :
  • Chemistry  from  routine
  • protein  specific  Y  evidence  diabetes
  • lipids
  • drugs  therapeutic
  • Abuse  from  drugs
  • Antioxidants

General Characteristics Yumizen G400 and G200

  • Innovative user interface and easy to operate 
  • QA 
  • Master calibration curve (no need for calibration)
  • Barcode reading capacity
  • External data storage (USB device)
  • Ready-to-use reagents
  • 3 reference measurement methods:
    coagulation
    turbidimetric
    chromogenic
  • 120 seconds maximum measurement
  • Free of mantenimient
  • Internal storage capacity of 1000 results
  • multiple connectivities
  • Laboratory information system
  • Optional Yumizen G data software

HORIBA medical

HORIBA Medical is a world leader in the hematology market. It is present in more than 110 countries on five continents